Apexigen, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 32.07 million compared to USD 28.92 million a year ago. Basic loss per share from continuing operations was USD 1.62 compared to USD 1.6 a year ago.
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |